• on the research front

    Dr. Howard has had a hand – literally – in The International Dermal Institute’s research and development of Dermalogica products for over 18 years. Now, as Vice President of Technical Development and Global Education, Diana takes her expertise to professional skin therapists and media outlets worldwide, speaking on the latest scientific developments in skin care.

    This month, professional skin therapists and trade press from around the world learned the latest about sensitization and inflammation from Dr. Diana Howard on behalf of The International Dermal Institute. IDI is on the forefront of research that explores the difference between neurogenic inflammation and immunogenic inflammation in skin.

    In the Middle East, Asia and Europe, Dr. Howard presented fascinating information on how stress through neurogenic inflammation can cause sensitivity. She also presented this information to eager skin therapists and trade press in Paris, Diegem, Belgium and Utrecht, Netherlands.

    Dr. Howard wrapped up her whirlwind world tour in Madrid, Spain with a lecture that revealed the “Fact, Fiction and Fantasy” of what’s real and what’s hype in the world of cosmetic ingredients.

    IDI is at the forefront of skin and ingredient research, and Dr. Diana Howard is dedicated to bringing her knowledge to the masses! Stay tuned for more skin and science updates from IDI, Dermalogica and Dr. Diana Howard!


    • Christopher Says:

      Being on the research front must allow Dr. Howard tons of scientific data to support why the products work. I am an RN who really requires studies, research and data driven articles to demonstrate quantifiable resutls to Medical Doctors in their practice. If a product works, how has that been determined? were 1,000 women tested and skin conditions like hyperpigmentation measured? What about self-reported perception surveys on products?
      Dr. Howard does a great job explaning the agin or pigmentaion process but the whole story of research data is absent. pleasd advise.

      June 4, 2011 at 4:31 am
      • admin's Response:

        The International Dermal Institute conducts all of the testing for Dermalogica research and development on formulations and product efficacy. The panel size varies with the individual product that we are testing. In general our panel sizes vary from 50 to 100 participants. Whenever possible we use instrumentation to quantify and provide an objective assessment of the product results rather than rely on subjective comments from the panelists. For pigmentation studies we might enlist 20 women with melasma, 20 women or men with sun induced hyperpigmentation, 20 with post inflammatory hyperpigmentation and 40 unknown cause. At the outset of the testing, we measure pigmentation using a Mexameter instrument in the lab that measures actual pigmentation in the skin. The panelists are given explicit instructions on how to use the product and come in for measurements every 2 weeks until the completion of the study ( in the case of pigmentation it is generally 12 weeks) . The data points are plotted via computer and results summarized. The results are not published outside of our organization but are available for the FDA or other such regulatory body that might request claims substantiation data. We tend to not use before and after pictures as the use of such illustrations in our industry is tainted by questions of “retouched” photos. Oftentimes, we do share the actual data, for example in UltraCalming™ studies we shared all of the redness reduction data at our launches. I hope this clarifies your question on research data.

        Dr. Diana Howard

        June 15, 2011 at 5:09 pm

    Leave a Comment

    Terms in bold are required.

    (will not be published)